EE200200252A - Use of Antibodies as Vaccines; Pharmaceutical Compositions Containing Antibodies; - Google Patents

Use of Antibodies as Vaccines; Pharmaceutical Compositions Containing Antibodies;

Info

Publication number
EE200200252A
EE200200252A EEP200200252A EEP200200252A EE200200252A EE 200200252 A EE200200252 A EE 200200252A EE P200200252 A EEP200200252 A EE P200200252A EE P200200252 A EEP200200252 A EE P200200252A EE 200200252 A EE200200252 A EE 200200252A
Authority
EE
Estonia
Prior art keywords
antibodies
vaccines
pharmaceutical compositions
compositions containing
containing antibodies
Prior art date
Application number
EEP200200252A
Other languages
Estonian (et)
Inventor
Loibner Hans
Eckert Helmut
Himmler Gottfried
Original Assignee
Igeneon Krebs-Immuntherapie Forschungs- Und Entwicklungs-Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igeneon Krebs-Immuntherapie Forschungs- Und Entwicklungs-Ag filed Critical Igeneon Krebs-Immuntherapie Forschungs- Und Entwicklungs-Ag
Publication of EE200200252A publication Critical patent/EE200200252A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
EEP200200252A 1999-11-16 2000-11-15 Use of Antibodies as Vaccines; Pharmaceutical Compositions Containing Antibodies; EE200200252A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0192799A AT409086B (en) 1999-11-16 1999-11-16 NEW USE OF ANTIBODIES AS VACCINE
PCT/EP2000/011306 WO2001035989A2 (en) 1999-11-16 2000-11-15 Use of anti-idiotypical antibodies as vaccines against cancer

Publications (1)

Publication Number Publication Date
EE200200252A true EE200200252A (en) 2003-06-16

Family

ID=3524036

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200252A EE200200252A (en) 1999-11-16 2000-11-15 Use of Antibodies as Vaccines; Pharmaceutical Compositions Containing Antibodies;

Country Status (24)

Country Link
EP (1) EP1229936B1 (en)
JP (1) JP2003514028A (en)
KR (1) KR20020060968A (en)
CN (1) CN1390138A (en)
AT (1) AT409086B (en)
AU (1) AU780853B2 (en)
BR (1) BR0015597A (en)
CA (1) CA2391927A1 (en)
CZ (1) CZ20021707A3 (en)
DE (1) DE50006526D1 (en)
DK (1) DK1229936T3 (en)
EE (1) EE200200252A (en)
ES (1) ES2218272T3 (en)
HU (1) HUP0204216A2 (en)
IL (1) IL149614A0 (en)
IS (1) IS6381A (en)
MX (1) MXPA02004942A (en)
NO (1) NO20022333L (en)
NZ (1) NZ518669A (en)
PL (1) PL356770A1 (en)
PT (1) PT1229936E (en)
SK (1) SK6542002A3 (en)
TR (1) TR200401267T4 (en)
WO (1) WO2001035989A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017108A (en) * 1975-04-17 1977-04-12 Archibald Kenrick And Sons Limited Window stay
US6294171B2 (en) * 1999-09-14 2001-09-25 Milkhaus Laboratory, Inc. Methods for treating disease states comprising administration of low levels of antibodies
AT410172B (en) * 2000-03-21 2003-02-25 Igeneon Gmbh METHOD FOR PRODUCING VACCINE FORMULATION
AT410637B (en) * 2001-06-01 2003-06-25 Igeneon Krebs Immuntherapie USE OF POLYCLONAL IMMUNOGLOBULINES
AT502293B1 (en) * 2002-05-15 2008-03-15 Igeneon Krebs Immuntherapie IMMUNOGENERAL, MONOCLONAL ANTIBODY
AT500648B1 (en) 2002-08-12 2010-03-15 Igeneon Krebs Immuntherapie SET FOR THE TREATMENT OF CANCER PATIENTS
KR100522526B1 (en) * 2002-11-28 2005-10-19 주식회사 바이넥스 Method of Preparing Dendritic cell for Immunotherapy
AT500650B1 (en) * 2003-04-17 2009-11-15 Altropus Gmbh IMMUNOGENIC RECOMBINANT ANTIBODY
WO2007024825A2 (en) * 2005-08-26 2007-03-01 Genway Biotech, Inc. Immunoaffinity separation and analysis compositions and methods
EP2044949A1 (en) * 2007-10-05 2009-04-08 Immutep Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response
GB201322626D0 (en) 2013-12-19 2014-02-05 Immutep S A Combined preparations for the treatment of cancer
US20180008702A1 (en) * 2014-12-05 2018-01-11 Celltrion Inc. Adjuvant composition containing at least one influenza virus neutralizing and binding molecule and vaccine composition containing same
GB201500374D0 (en) 2015-01-09 2015-02-25 Immutep S A Combined preparations for the treatment of cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135536A1 (en) * 1983-01-28 1985-04-03 Centocor, Inc. Anti-idiotypic antibodies to t cell antigen receptors
EP0380607B1 (en) * 1988-05-17 1994-12-14 FERRONE, Soldano Anti-idiotype antibodies to anti-human high molecular weight-melanoma associated antigen
US20030072751A1 (en) * 1990-03-14 2003-04-17 Heribert Bohlen Idiotypic vaccination against b cell lymphoma
IT1254315B (en) * 1992-03-27 1995-09-14 Mini Ricerca Scient Tecnolog ANTI-IDIOTYPIC MONOCLONAL ANTIBODIES DIRECT AGAINST ANTI-TNF ANTIBODIES.
EP0651656A1 (en) * 1992-07-08 1995-05-10 Schering Corporation Use of gm-csf as a vaccine adjuvant
ES2197217T3 (en) * 1994-12-28 2004-01-01 University Of Kentucky Research Foundation 3H1 ANTI-ID-MURINO MONOCLONAL ANTIBODY.

Also Published As

Publication number Publication date
PT1229936E (en) 2004-09-30
TR200401267T4 (en) 2004-07-21
DK1229936T3 (en) 2004-08-30
CZ20021707A3 (en) 2002-10-16
PL356770A1 (en) 2004-07-12
NO20022333L (en) 2002-06-03
ATA192799A (en) 2001-10-15
WO2001035989A2 (en) 2001-05-25
EP1229936B1 (en) 2004-05-19
JP2003514028A (en) 2003-04-15
KR20020060968A (en) 2002-07-19
AU2357201A (en) 2001-05-30
EP1229936A2 (en) 2002-08-14
NZ518669A (en) 2003-08-29
DE50006526D1 (en) 2004-06-24
CN1390138A (en) 2003-01-08
AU780853B2 (en) 2005-04-21
NO20022333D0 (en) 2002-05-15
MXPA02004942A (en) 2003-10-14
BR0015597A (en) 2002-07-23
IL149614A0 (en) 2002-11-10
CA2391927A1 (en) 2001-05-25
HUP0204216A2 (en) 2003-04-28
WO2001035989A3 (en) 2001-10-04
SK6542002A3 (en) 2002-11-06
IS6381A (en) 2002-05-14
AT409086B (en) 2002-05-27
ES2218272T3 (en) 2004-11-16

Similar Documents

Publication Publication Date Title
EE200200486A (en) Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and processes for their preparation
EE05183B1 (en) Azabitic compounds, their preparation and use as pharmaceuticals, and the pharmaceutical composition containing them
ATE331529T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING ANTIGEN
NO20024175L (en) Acetidine derivatives, their preparation and pharmaceutical compositions containing the compounds
DE60045324D1 (en) vaccine composition
FI991485A0 (en) New pharmaceutical composition
EE200300207A (en) Heterocyclylalkylpiperidine Derivatives, Methods of Preparation, and Pharmaceutical Composition
EE200300080A (en) Polyarylcarboxamide Compounds, Their Preparation and Use as Lipid-lowering Agents, and Pharmaceutical Composition Containing Them
ATE321569T1 (en) COMBINED VACCINE COMPOSITIONS
EE04799B1 (en) Compounds useful as anti-inflammatory agents, methods of making these compounds, and pharmaceutical compositions containing them
NO20015175D0 (en) Pharmaceutical composition
EE200300054A (en) Bicyclopyrazoles acting as kinase inhibitors, process for their preparation, use and pharmaceutical compositions containing them
EE05034B1 (en) Bicyclic heterocyclic compounds, pharmaceutical compositions containing them and methods for their preparation
IL162185A0 (en) Phenylpropionate derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same
EE05020B1 (en) The pharmaceutical composition of G1buride
EE200100653A (en) Indolylpiperidine Compounds, Method of Preparation, Composition and Use thereof
HUP0401747A3 (en) Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
EE200200252A (en) Use of Antibodies as Vaccines; Pharmaceutical Compositions Containing Antibodies;
NO20021898L (en) Pharmaceutical composition containing ciclesonide for application to mucosa
ATE350016T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING BICALUTAMID
ITMI20011637A0 (en) PHARMACEUTICAL COMPOSITION CONTAINING CITALOPRAM
PT1227817E (en) AQUOSA PHARMACEUTICAL COMPOSITION CYCLOSONIDE CONTAINING
FI4488U1 (en) Pharmaceutical composition
FI20012140A (en) Novel quaternary compounds, compositions containing them and uses thereof
EE200300548A (en) Novel 5-thio-β-D-xylopyranoside derivatives, process for their preparation, pharmaceutical compositions containing them and their therapeutic use